Antiviral drug 'Clevira' repurposed for treating mild to moderate Covid-19 patients

Antiviral drug 'Clevira' repurposed for treating mild to moderate Covid-19 patients Clevira, an antiviral formulation, has received regulatory approval as a supportive treatment for mild to moderate Covid-19 cases, the Chennai-based pharmaceutical company said. https://ift.tt/eA8V8J